SCALING-RESISTANT AND YELLOWING-RESISTANT REVERSE OSMOSIS COMPOSITE MEMBRANE AND PREPARATION METHOD THEREOF

Abstract

The present disclosure relates to a scaling-resistant and yellowing-resistant composite reverse osmosis membrane and a preparation method thereof. By modifying the stability and yellowing of a coating of the reverse osmosis membrane, and grafting 2-(methacryloyloxy)ethyl)dimethyl-3-sulphoproyl) ammonium hydroxide (MEDSAH) and ethylene glycol methacrylate (EGMA) as amphoteric monomers and N-(isobutoxymethyl)acrylamide (IBMA) as yellowing-resistant particles on a surface of the reverse osmosis membrane using active polymerization, the present disclosure forms a three-network high-performance PMEDSAH/PEGMA/PIBMA composite coating. By active regulation of a polyamide (PA) layer through the three systems, the reverse osmosis membrane has high compatibility due to PMEDSAH, and stability, high hydrophilicity and anti-protein fouling property due to PEGMA, as well as yellowing-resistant property by coating PIBMA on the surface. The test results show that the reverse osmosis membrane prepared by the present disclosure has excellent stability and yellowing-resistant property. And the flux and salt rejection are also higher than those of the existing reverse osmosis membranes.

Claims

1. A preparation method of a scaling-resistant and yellowing-resistant composite reverse osmosis membrane, wherein, comprising the following steps: S1 dissolving ethylene glycol methacrylate (EGMA) in anisole, and ultrasonically stirring to mix evenly; then sequentially adding an initiator and 2-dodecylsulfanylthiocarbonylsulfanyl-2-methyl propionic acid (DMP) as a chain transfer agent, sealing and vacuum mixing at 25? C. for 5 h to obtain a product; precipitating the product into a large amount of petroleum ether, separating by filtration, and then vacuum drying at 40? C. for 24 h to obtain poly(ethylene glycol) methacrylate (PEGMA) particles; S2 immersing a commercial polysulfone supported membrane in pure water in advance for cleaning, and removing excess water via a rubber roller, then putting in an aqueous phase solution for 15 s-60 s and in an oil phase solution for 15 s-60 s, and performing heat treatment to obtain a primary composite reverse osmosis membrane; and S3 adding 2-(methacryloyloxy)ethyl)dimethyl-3-sulphoproyl) ammonium hydroxide (MEDSAH) and N-(isobutoxymethyl)acrylamide (IBMA) to tetrahydrofuran to mix evenly, and then adding azobisisobutyronitrile (AIBN) as an initiator to obtain a solution; putting the primary composite reverse osmosis membrane prepared in the step (2) in the solution for ultrasonic reaction at 25? C. for 24 h, to obtain the scaling-resistant and yellowing-resistant composite reverse osmosis membrane.

2. The preparation method according to claim 1, wherein, in the step (1), a mass ratio of EGMA, the initiator and DMP as the chain transfer agent is: (1-3):(0.005-0.008):(0.002-0.004).

3. The preparation method according to claim 1, wherein, in the step (1), the initiator is a mixture of AIBN and benzoyl peroxide (BPO) at a mass ratio of 1:1.

4. The preparation method according to claim 1, wherein, in the step (2), the aqueous phase solution is composed of the following components in mass percentage: the PEGMA particles 0-1%, a monomer 2.5%, and triethylamine 0.2%.

5. The preparation method according to claim 1, wherein, in the step (2), the monomer in the aqueous phase solution is one of p-phenylenediamine, m-phenylenediamine and o-phenylenediamine.

6. The preparation method according to claim 1, wherein, in the step (2), the oil phase solution is composed of the following components in mass percentage: 0.08% trimesoyl chloride, and a balance of a n-hexane solution;

7. The preparation method according to claim 1, wherein, in the step (2), the heat treatment is carried out at 80? C. for 10 min.

8. The preparation method according to claim 1, wherein, in the step (3), a mass ratio of MEDSAH, IBMA and AIBN as the initiator is: (1-4):(1-3):(0.003-0.005).

Description

DETAILED DESCRIPTION OF THE EMBODIMENTS

[0015] Specific examples of the scaling-resistant and yellowing-resistant composite reverse osmosis membrane of the present disclosure are provided below.

Example 1

[0016] EGMA is added to anisole, ultrasonically stirring to mix evenly. Then, AIBN as the initiator and BPO at the mass ratio of 1:1 and DMP are sequentially added, sealing and vacuum mixing at 25? C. for 5 h to obtain the product. The product is precipitated into a large amount of petroleum ether, separating via filtration, and vacuum drying at 40? C. for 24 h to obtain the PEGMA particles. The mass ratio of EGMA, the initiator and DMP is 1:0.005:0.002.

[0017] The commercial polysulfone supported membrane is immersed in pure water in advance for cleaning, and the excess water is removed via the rubber roller. Then, the commercial polysulfone supported membrane is put in the aqueous phase solution composed of 0.5% PEGMA, 2.5% m-phenylenediamine and 0.15% triethylamine for 15 s, and then put in the oil phase solution composed of the n-hexane solution containing 0.08% trimesoyl chloride for 30 s. Then, the heat treatment is carried out at 80? C. for 10 min to obtain the primary composite reverse osmosis membrane.

[0018] MEDSAH and IBMA are added into tetrahydrofuran to mix evenly, then AIBN as the initiator is added to obtain the solution. The mass ratio of MEDSAH, IBMA and AIBN is 1:2:0.003. The primary composite reverse osmosis membrane is put in the solution for ultrasonic reaction at 25? C. for 24 h, to obtain the scaling-resistant and yellowing-resistant composite reverse osmosis membrane.

Example 2

[0019] The implementation is the same as that in Example 1 except that the mass ratio of EGMA, the initiator and DMP is 3:0.008:0.004 in the synthesis of the PEGMA particles, to obtain the scaling-resistant and yellowing-resistant composite reverse osmosis membrane.

Example 3

[0020] The implementation is the same as that in Example 1 except that the mass ratio of EGMA, the initiator and DMP is 2:0.006:0.003 in the synthesis of the PEGMA particles, to obtain the scaling-resistant and yellowing-resistant composite reverse osmosis membrane.

Example 4

[0021] The preparation process of the PEGMA particles and the primary composite reverse osmosis membrane is the same as that in Example 1.

[0022] MEDSAH and IBMA are added into tetrahydrofuran to mix evenly, then AIBN as the initiator is added to obtain the solution. The mass ratio of MEDSAH, IBMA and AIBN is 3:2:0.004. The primary composite reverse osmosis membrane is put in the solution for ultrasonic reaction at 25? C. for 24 h, to obtain the scaling-resistant and yellowing-resistant composite reverse osmosis membrane.

Example 5

[0023] The preparation process of the PEGMA particles and the primary composite reverse osmosis membrane is the same as that in Example 1.

[0024] MEDSAH and IBMA are added into tetrahydrofuran to mix evenly, then AIBN as the initiator is added to obtain the solution. The mass ratio of MEDSAH, IBMA and AIBN is 4:3:0.005. The primary composite reverse osmosis membrane is put in the solution for ultrasonic reaction at 25? C. for 24 h, to obtain the scaling-resistant and yellowing-resistant composite reverse osmosis membrane.

Comparative Example 1

[0025] The commercial polysulfone supported membrane is immersed in pure water in advance for cleaning, and the excess water is removed via the rubber roller. Then, the commercial polysulfone supported membrane is put in the aqueous phase solution composed of 2.5% m-phenylenediamine and 0.15% triethylamine for 15 s, and then put in the oil phase solution composed of the n-hexane solution containing 0.08% trimesoyl chloride for 30 s. Then, the heat treatment is carried out at 80? C. for 10 min to obtain the primary composite reverse osmosis membrane.

Comparative Example 2

[0026] The commercial polysulfone supported membrane is immersed in pure water in advance for cleaning, and the excess water is removed via the rubber roller. Then, the commercial polysulfone supported membrane is put in the aqueous phase solution composed of 2.5% m-phenylenediamine and 0.15% triethylamine for 15 s, and then put in the oil phase solution composed of the n-hexane solution containing 0.08% trimesoyl chloride for 30 s. Then, the heat treatment is carried out at 80? C. for 10 min to obtain the primary composite reverse osmosis membrane.

[0027] MEDSAH and IBMA are added into tetrahydrofuran to mix evenly, then AIBN as the initiator is added to obtain the solution. The mass ratio of MEDSAH, IBMA and AIBN is 1:2:0.003. The primary composite reverse osmosis membrane is put in the solution for ultrasonic reaction at 25? C. for 24 h, to obtain the composite reverse osmosis membrane.

[0028] The membrane performance test of the examples and comparative examples is performed at 25? C. with the pH value of 7-8 and the pressure of 1.55 MPa, and using the NaCl aqueous solution with the concentration of 2000 ppm. And the scaling resistance is tested by contact angle.

TABLE-US-00001 TABLE 1 Flux, salt rejection and scaling resistance of the examples and comparative examples Contact Contact angle of Salt Salt angle of membrane Water flux rejection Water flux rejection membrane surface (L/m.sup.2 .Math. h at (% at initial (L/m.sup.2 .Math. h at (% at 180 surface (? at 180 Serial No. initial state) state) 180 day) day) (? at 0 day) day) Comparative 33.7 97.8 25.8 96.3 56.4 88.2 Example 1 Comparative 40.8 97.6 33.6 96.1 53.1 79.6 Example 2 Example 1 52.1 98.9 51.3 98.6 35.7 36.8 Example 2 49.8 99.2 49.0 99.0 34.4 34.6 Example 3 57.3 99.1 56.8 98.9 37.3 38.7 Example 4 55.2 98.7 54.9 98.5 40.1 42.5 Example 5 56.3 99.6 56.0 99.3 38.5 39.2

[0029] It can be seen from Table 1 that the scaling-resistant and yellowing-resistant composite reverse osmosis membrane prepared by the method of the present disclosure has high flux, hydrophilic property, excellent scaling-resistant and yellowing-resistant properties. The performance and stability of the membrane are greatly improved by the three-network high-performance PMEDSAH/PEGMA/PIBMA composite coating.

[0030] It shall be pointed out that the above examples are only the preferred examples of the present disclosure, not intended to limit the present disclosure. Various modifications and improvements made within the concept and principle of the present disclosure shall fall within the protection scope of the present disclosure.